-

ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will showcase its Process Lifecycle Suite, part of the ValGenesis Smart GxP™ platform, at BioProcessing Summit Europe 2026, taking place March 10-12 in Barcelona. The event brings together bioprocessing innovators, scientists, and decision-makers shaping the future of modern biomanufacturing.

Attendees are invited to stop by Booth No. 35 to connect with the ValGenesis team and learn more.

Share

Many pharmaceutical and biotechnology companies, including cell and gene therapy developers, continue to manage process lifecycle activities through siloed systems and manual workflows. At Booth No. 35, ValGenesis will demonstrate how Process Lifecycle Suite connects and standardizes lifecycle execution, building quality into every stage of drug development while improving traceability, ensuring proactive compliance, and maintaining a continued state of control.

“Process validation is not a one-time event—it is an ongoing lifecycle that must remain connected and inspection-ready,” said Steve Reynolds, chief revenue officer at ValGenesis. “We look forward to sharing how organizations can transform fragmented validation activities into a connected, end-to-end lifecycle strategy.”

Why visit Booth No. 35?

  • One-on-one consultations tailored to organizational maturity, compliance, and performance goals
  • Strategies for implementing a digital, end-to-end process lifecycle framework
  • Best practices for maintaining inspection readiness through continuous lifecycle management
  • Methods to scale process lifecycle execution across global manufacturing networks

Attendees are invited to stop by Booth No. 35 to connect with the ValGenesis team and learn more.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit www.valgenesis.com.

###

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis Inc.


Release Versions

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis Inc.

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...

ValGenesis to Host ValConnect Mumbai Focused on AI-Driven Validation

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in digital validation, will host ValConnect Innovation Day on Sept. 9 at the Hilton Mumbai International Airport, bringing together leaders from life sciences, technology, and manufacturing to examine the role of AI in validation, compliance, and quality across the GxP lifecycle. The one-day event, which concludes the 2026 ValConnect Innovation Day series, will focus on a central challenge facing life sciences organizations: how...

Leading Oncology Injectables Manufacturer Selects ValGenesis to Modernize Equipment Qualification

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation and compliance solutions, announced that a specialized Indian pharmaceutical joint venture focused on cytotoxic and oncology drug manufacturing, has selected the ValGenesis validation lifecycle management platform to modernize equipment qualification across its operations in India. The company manufactures injectable and sterile products for regulated global markets, operating state-of-the-...
Back to Newsroom